微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 0.32% | 113.33% | 557.14% | 91/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | -0.07% | 89.71% | 98.39% | 99/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -4.36% | 70.4% | -34.57% | 110/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -3.24% | 43.65% | -35% | 119/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -2.4% | -34.08% | -252.94% | 117/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | -0.68% | -126.67% | 95.38% | 115/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -14.73% | -734.91% | -156.17% | 127/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | -5.75% | -256.68% | -221.23% | 121/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -1.79% | -181.74% | -496.67% | 118/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | -0.3% | -105.67% | -112.93% | 111/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.32% | -94.55% | -36.78% | 94/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 3.67% | -88.32% | 67.58% | 78/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.19% | -90.52% | -58.6% | 78/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 5.29% | -63.54% | -87.57% | 15/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 42.55% | 42.21% | 35.42% | 9/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 31.42% | 29.35% | 36.02% | 15/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 23.1% | 53.59% | 59.2% | 14/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 14.51% | 127.79% | -51.5% | 13/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 29.92% | 48.49% | 23.18% | 19/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 24.29% | 23.99% | 61.5% | 18/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 15.04% | 51.31% | 136.11% | 23/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 6.37% | 286.06% | -68.39% | 26/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 20.15% | 51.39% | 2.86% | 51/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 19.59% | 86.04% | 97.08% | 29/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 9.94% | 76.87% | 502.42% | 44/141 | 15.17% | 杭州博拓生物科技 | 108.13% | 行业排名> |
| 2020-03-31 | 1.65% | 12.24% | -87.6% | 47/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 13.31% | 31.39% | 26.4% | 62/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 10.53% | 30.16% | 87.37% | 27/141 | 10.54% | 祥生医疗科技 | 28.56% | 行业排名> |
| 2019-06-30 | 5.62% | 36.41% | 282.31% | 38/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 1.47% | 15.75% | -85.49% | 37/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 10.13% | -4.16% | 25.22% | 72/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 8.09% | -9.41% | 96.36% | 31/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 4.12% | -25.23% | 224.41% | 35/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 1.27% | -36.18% | -87.98% | 39/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 10.57% | -33.85% | 18.37% | 64/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 8.93% | 2% | 62.07% | 24/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 5.51% | -23.9% | 176.88% | 31/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 1.99% | 2% | -87.55% | 27/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 15.98% | -4.6% | 120.72% | 32/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-06-30 | 7.24% | 2% | -56.78% | 17/141 | 6.35% | 安图生物 | 28% | 行业排名> |